ACA
Affinity Capital Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Buy |
3,433
+10
| +0.3% | +$1.86K | 0.11% | 84 |
|
|
2025
Q1 | $599K | Buy |
3,423
+4
| +0.1% | +$700 | 0.12% | 81 |
|
|
2024
Q4 | $614K | Buy |
3,419
+9
| +0.3% | +$1.62K | 0.12% | 81 |
|
|
2024
Q3 | $673K | Buy |
3,410
+8
| +0.2% | +$1.58K | 0.13% | 84 |
|
|
2024
Q2 | $584K | Sell |
3,402
-25
| -0.7% | -$4.29K | 0.12% | 86 |
|
|
2024
Q1 | $624K | Buy |
3,427
+37
| +1% | +$6.74K | 0.14% | 78 |
|
|
2023
Q4 | $525K | Sell |
3,390
-55
| -2% | -$8.52K | 0.13% | 82 |
|
|
2023
Q3 | $514K | Buy |
3,445
+173
| +5% | +$25.8K | 0.14% | 83 |
|
|
2023
Q2 | $441K | Buy |
3,272
+53
| +2% | +$7.14K | 0.12% | 80 |
|
|
2023
Q1 | $513K | Sell |
3,219
-30
| -0.9% | -$4.78K | 0.16% | 75 |
|
|
2022
Q4 | $525K | Buy |
3,249
+6
| +0.2% | +$970 | 0.18% | 62 |
|
|
2022
Q3 | $435K | Buy |
3,243
+5
| +0.2% | +$671 | 0.15% | 66 |
|
|
2022
Q2 | $496K | Sell |
3,238
-43
| -1% | -$6.59K | 0.17% | 65 |
|
|
2022
Q1 | $532K | Buy |
3,281
+54
| +2% | +$8.76K | 0.17% | 65 |
|
|
2021
Q4 | $437K | Buy |
3,227
+1
| +0% | +$135 | 0.13% | 74 |
|
|
2021
Q3 | $348K | Buy |
3,226
+1
| +0% | +$108 | 0.12% | 84 |
|
|
2021
Q2 | $363K | Buy |
3,225
+236
| +8% | +$26.6K | 0.12% | 85 |
|
|
2021
Q1 | $323K | Buy |
+2,989
| New | +$323K | 0.12% | 86 |
|